In recent years, decreased expression of PTPN12 has been shown to be correlated with the development and progression of different human cancers, including breast cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma [12, 14, 17, 25]. This evidence concerns the gene PTPN12 and cancer.